Let’s Talk Risk with the Society for Risk Analysis, the world’s leading authority on risk science and its applications, helps bring clarity to the world of risk, uncertainty, and ambiguity. Visit www.sra.org for more information on the topics discussed in these episodes and for more studies found in Risk Analysis: An International Journal
Compound Hazards: Should I Stay or Should I Go?
Robyn Wilson, Ph.D., Ohio State University, and Gina Eosco, Ph.D., NOAA, discuss compound hazards and how that impacts the decision making process for individuals and communities when threatened by both extreme weather events and COVID-19. What actions should people take when faced with both evacuation and stay-at-home orders?
COVID-19 Impacts on Risk Research
Four panelists discuss the impacts of the COVID-19 pandemic on their research projects in various disciplines of risk analysis.
Gabrielle Wong-Parodi, Ph.D., Stanford University
Khara Grieger, Ph.D., North Carolina State University
Mark Borsuk, Ph.D., Duke University
Roshanak Nateghi, Ph.D., Purdue University
Insights into Reopening the Economy
Robin Cantor, Ph.D., and Dubravka Tosic, Ph.D., Berkeley Research Group, discuss how businesses and non-profits can begin to re-open and regain their customers post-COVID-19.
COVID-19 Pandemic: Is History Doomed to Repeat Itself?
Vicki Bier, Ph.D., University of Wisconsin, discusses lessons learned from the 1918 Spanish Flu Pandemic.
New Challenges for Risk Analysis from COVID-19
Rae Zimmerman, Ph.D., research professor at NYU Wagner, discusses the new challenges for risk analysts posed by the COVID-19 pandemic, from a NYC perspective.
Emerging Health Technologies: Do The Risks Outweigh The Rewards?
Sally Wyatt, Ph.D., Maastricht University, and Marie-Valentine Florin, Ecole Polytechnique Federale de Lausanne (EPFL), discuss direct-to-consumer genetic testing and human genome editing with an overarching theme of risk vs. reward. This episode is hosted by Catherine Wong, University of Luxembourg.